|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13,444.00 GBX | -1.12% |
|
-1.09% | +28.43% |
| 12/12 | European health regulator recommends approval for GSK's twice-yearly asthma drug | RE |
| 12/12 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
Transcripts
Search
06/11 | ||
29/07 | ||
04/06 | ||
28/05 | ||
29/04 | ||
06/02 | ||
13/01 | ||
15/11 | ||
12/11 | ||
04/11 | ||
24/24/24 | ||
10/24/10 | ||
25/24/25 | ||
21/24/21 | ||
25/24/25 | ||
22/24/22 | ||
08/24/08 | ||
09/24/09 | ||
09/23/09 | ||
23/23/23 | ||
11/23/11 | ||
28/23/28 | ||
06/23/06 | ||
27/23/27 | ||
09/23/09 |
No results for this search
Filters
Headlines
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- Transcripts
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition